Application 205103

Type
NDA
Sponsor
GENUS LIFESCIENCES

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001YOSPRALAASPIRIN; OMEPRAZOLETABLET, DELAYED RELEASE;ORAL81MG;40MGYesNo
002YOSPRALAASPIRIN; OMEPRAZOLETABLET, DELAYED RELEASE;ORAL325MG;40MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
64950-424Yospralaaspirin and omeprazoleGenus Lifesciences Inc.NDACurrent
64950-424Yospralaaspirin and omeprazoleGenus Lifesciences Inc.NDACurrent
64950-424Yospralaaspirin and omeprazoleGenus Lifesciences Inc.NDACurrent
64950-424Yospralaaspirin and omeprazoleGenus Lifesciences Inc.NDACurrent
64950-425Yospralaaspirin and omeprazoleGenus Lifesciences Inc.NDACurrent
64950-425Yospralaaspirin and omeprazoleGenus Lifesciences Inc.NDACurrent
64950-425Yospralaaspirin and omeprazoleGenus Lifesciences Inc.NDACurrent
64950-425Yospralaaspirin and omeprazoleGenus Lifesciences Inc.NDACurrent
68071-5102YospralaYospralaNuCare Pharmaceuticals,Inc.NDACurrent
68071-5102YospralaYospralaNuCare Pharmaceuticals,Inc.NDACurrent
69597-348ASPIRIN/OMEPRAZOLEaspirin and omeprazoleBasiemNDACurrent
70347-081YOSPRALAAspirin and OmeprazoleAralez Pharmaceuticals Us Inc.NDACurrent
70347-325YOSPRALAAspirin and OmeprazoleAralez Pharmaceuticals Us Inc.NDACurrent
71800-012Yospralaaspirin and omeprazoleInnovida Phamaceutique CorporationNDACurrent
71800-012Yospralaaspirin and omeprazoleInnovida Phamaceutique CorporationNDACurrent
71800-012Yospralaaspirin and omeprazoleInnovida Phamaceutique CorporationNDACurrent
71800-014aspirin and omeprazole delayed-release tabaspirin and omeprazoleInnovida Phamaceutique CorporationNDACurrent
71800-014aspirin and omeprazole delayed-release tabaspirin and omeprazoleInnovida Phamaceutique CorporationNDACurrent
71800-014aspirin and omeprazole delayed-release tabaspirin and omeprazoleInnovida Phamaceutique CorporationNDACurrent
71800-016Yospralaaspirin and omeprazoleInnovida Phamaceutique CorporationNDACurrent
71800-016Yospralaaspirin and omeprazoleInnovida Phamaceutique CorporationNDACurrent
71800-016Yospralaaspirin and omeprazoleInnovida Phamaceutique CorporationNDACurrent
71800-018aspirin and omeprazole delayed-release tabaspirin and omeprazoleInnovida Phamaceutique CorporationNDACurrent
71800-018aspirin and omeprazole delayed-release tabaspirin and omeprazoleInnovida Phamaceutique CorporationNDACurrent
71800-018aspirin and omeprazole delayed-release tabaspirin and omeprazoleInnovida Phamaceutique CorporationNDACurrent
73457-415aspirin and omeprazole delayed-release tabaspirin and omeprazoleInnovida Therapeutique CorporationNDACurrent
73568-004Yospralaaspirin and omeprazolePHARMACEUTIKA LTDNDACurrent
73568-005Yospralaaspirin and omeprazolePHARMACEUTIKA LTDNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
80416SUPPL 2024-11-25
80415SUPPL 2024-11-25
80315SUPPL 2024-11-22
74825SUPPL 2023-07-20
74783SUPPL 2023-07-19
70450SUPPL2022-03-09
70443SUPPL2022-03-09
70432SUPPL2022-03-07
67366SUPPL2021-05-03
67365SUPPL2021-05-03
67289SUPPL2021-04-30
65430SUPPL2020-12-01
65370SUPPL2020-11-30
65369SUPPL2020-11-30
54584SUPPL2018-06-14
54526SUPPL2018-06-12
54525SUPPL2018-06-12
53639ORIG2018-04-09
49972SUPPL2017-10-06
49951SUPPL2017-10-05
45386ORIG2016-09-19
45387ORIG2016-09-15